Back to trial detailsIntake questionnaire
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Applying to Benefis Healthcare- Sletten Cancer Institute · Great Falls, Montana
Answer a few short questions to share with the research team.
0 of 4 answered